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Legionella pneumophila is an intracellular pathogen that replicates within alveolar
macrophages. Through its ability to activate multiple host innate immune components,
L. pneumophila has emerged as a useful tool to dissect inﬂammatory signaling pathways
in macrophages. However the resolution of L. pneumophila infection in the lung requires
multiplecelltypesandabundantcrosstalkbetweenimmunecells.Fewstudieshaveexam-
ined the coordination of events that lead to effective immune control of the pathogen. Here
we discuss L. pneumophila interactions with macrophages and dendritic cell subsets and
highlight the paucity of knowledge around how these interactions recruit and activate other
immune effector cells in the lung.
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INTRODUCTION
Members of the genus Legionella are Gram-negative, facultative
intracellular bacteria of amoebae, including free-living, freshwa-
ter, or soil amoebae (Rowbotham, 1980; Tyndall and Domingue,
1982; Fields, 1996). Legionella pneumophila was the ﬁrst species
described and is the known causative agent of an acute form
of pneumonia termed Legionnaires’ disease (Fraser et al., 1977;
McDade et al., 1977). Humans become secondarily infected after
inhalingoraspiratingaerosolscontainingbacteria.Uponitstrans-
mission to the human lung, L. pneumophila enters and replicates
in alveolar macrophages, leading to inﬂammation and disease
(Horwitz and Silverstein, 1980; Horwitz, 1983a). Replication in
macrophages is thus a hallmark of L. pneumophila infection.
Within macrophages, the bacteria block phagolysosome fusion
and intercept vesicles trafﬁcking in the secretory pathway (Hor-
witz, 1983b; Kagan and Roy, 2002). The resulting Legionella-
containing vacuole (LCV), ultimately takes on properties of the
rough endoplasmic reticulum (Roy and Tilney,2002; Isberg et al.,
2009). The formation of the LCV is dependent on a functional
Dot/IcmTypeIVBsecretionsystemusedbythepathogentodeliver
effectors into the host cell cytosol (Segal and Shuman,1997; Segal
et al., 1998; Vogel et al., 1998). At least 275 effectors have been
identiﬁed (Zhu et al., 2011), that target multiple and overlapping
host cell functions including host cell GTPase activity, phos-
phoinositide metabolism,protein secretion,apoptosis,eukaryotic
protein translation, ubiquitination, NF-κB activation and mito-
chondrial function, reviewed in (Franco et al., 2009; Isberg et al.,
2009; Weber et al., 2009; Hubber and Roy, 2010; Newton et al.,
2010).
REPLICATION OF L. PNEUMOPHILA IN MACROPHAGES
Macrophages and dendritic cells (DC) are important sen-
tinels of the immune system detecting infectious agents by
highly conserved microbial motifs, so-called pathogen-associated
molecular patterns (PAMPs; Janeway Jr., 1992). Pattern recog-
nition is mediated by a set of invariant pattern-recognition
receptors (PRRs) of which four families have been identi-
ﬁed: toll-like receptors (TLRs), retinoic acid-inducible gene-I
(RIG-I) like receptors (RLRs), C-type lectin receptors (CLRs),
and nucleotide-binding and oligomerization domain (NOD)-like
receptors (NLRs; Takeuchi and Akira, 2010). NLRs comprise a
large family of cytoplasmic PRRs of which only a few members
have been characterized in detail. Some NLRs form multiprotein
complexes called inﬂammasomes (Schroder and Tschopp, 2010)
and activation of these complexes leads to the cleavage of the cen-
traleffectormoleculecysteineproteasecaspase-1,inducingaform
of cell death known as pyroptosis which is accompanied by the
release of pyrogenic IL-1ß, IL-18, and IL-33 (Davis et al., 2011).
The ﬂagellin sensing Nlrc4 inﬂammasome plays a central role
inthedetectionofL.pneumophila,whichisthereasonmostinbred
strains of mice are resistant to L. pneumophila infection. The dis-
covery of the Nlrc4 inﬂammasome began with the observation
that macrophages derived from most mouse strains restrict bac-
terial replication with the notable exception of the A strain (often
called A/J, although this terminology refers only to mice derived
directly from the Jackson or Janvier laboratories;Yamamoto et al.,
1988). Crosses between A mice and non-permissive C57BL/6
mice showed that the susceptibility of the A strain is controlled
by a single locus on mouse chromosome 13, designated Lgn1
(Beckers et al., 1995; Dietrich et al., 1995). Genetic studies then
identiﬁed the new NLR gene, Naip5, within this locus as respon-
sible for the increased susceptibility of A mice to infection (Diez
et al., 2003; Wright et al., 2003). Subsequent work showed that
Naip5-dependent restriction of L. pneumophila relies on a func-
tional copy of Naip5 as well as Nlrc4 and activation of caspase-1
(Zamboni et al., 2006). Restriction results from the presence of
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bacterial ﬂagellin in the host cytosol, and recognition of the
C-terminus of ﬂagellin is sufﬁcient for activation of the Nlrc4
inﬂammasome (Molofsky et al., 2006; Ren et al., 2006; Lightﬁeld
et al., 2008). Interestingly, the cytosolic localization of ﬂagellin
and/or restriction of replication depends on a functional Dot/Icm
type 4 secretion system (Amer et al., 2006; Molofsky et al., 2006;
Ren et al., 2006; Zamboni et al., 2006; Lamkanﬁ et al., 2007).
However, it is not known how the Dot/Icm system contributes
to the translocation of ﬂagellin into the host cytosol and whether
the detection of ﬂagellin by the inﬂammasome occurs directly or
indirectly with the help of cofactors.
While formation of the inﬂammasome leads to the activation
of caspase-1, as well as maturation and secretion of IL-1ß and IL-
18,neither cytokine makes a major contribution to the restriction
of L. pneumophila in vitro or in vivo (Amer et al., 2006; Zamboni
et al., 2006; Coers et al., 2007; Akhter et al., 2009; Miao et al.,
2010). Nevertheless, caspase-1 knockout macrophages are more
permissive for L. pneumophila replication and caspase1-deﬁcient
micearemoresusceptibletoL.pneumophila infection(Ameretal.,
2006; Zamboni et al., 2006). Caspase-1 activation upon bacterial
infection may also result from an alternative Nlrc4-independent
pathwaywhichrequirestheapoptosisassociatedspeck-likeprotein
(Asc), yet Asc is dispensable for restriction (Zamboni et al., 2006;
Case et al., 2009). Although depletion or inhibition of caspase-
1 activity leads to decreased targeting of bacteria to lysosomes
(Amer et al., 2006; Zamboni et al., 2006), the mechanism of
caspase-1-dependent restriction of L. pneumophila replication in
macrophages and in vivo is yet to be fully resolved. Activation
of the Nlrc4 inﬂammasome can lead to macrophage cell death
throughcaspase-1dependentporeformation,whichmayaccount
forreducedbacterialnumbersthroughmacrophagecelllysis(Case
et al., 2009; Silveira and Zamboni, 2010). Downstream molecules
such as caspase-7, interferon regulatory factor (IRF) 1 and IRF8
also play a signiﬁcant role in caspase-1 signaling and in the case
of caspase-7, this activation leads to increased macrophage apop-
tosis (Akhter et al., 2009; Fortier et al., 2009). caspase7-deﬁcient
micearealsomoresusceptibletoL.pneumophila infection(Akhter
et al., 2009). However, the ability of L. pneumophila to replicate
within macrophages in vitro does not necessarily equate with vir-
ulence in whole animals. For example, type I interferon (IFN-I)
receptor-deﬁcient macrophages, support enhanced replication of
L. pneumophila yet IFN-I receptor-deﬁcient mice are no more
susceptible to infection in vivo (Monroe et al., 2009; Ang et al.,
2010).
In contrast to macrophages derived from restrictive mouse
strains, human macrophages or monocytes allow robust replica-
tion of L. pneumophila despite the presence of Naip and Nlrc4
orthologues.HumanNlrc4andNaiparefunctionalbutonlydelay
L. pneumophila replication when overexpressed (Vinzing et al.,
2008) suggesting that the level of inﬂammasome activity may
restrictL.pneumophilareplicationinhumanscells,similartomice.
ArecentreportalsoshowedthathumanAscisabletorestrictbacte-
rialgrowthinacaspase-1-dependentandindependentmannerbut
is downregulated during L. pneumophila infection of monocytic
THP-1 cells (Abdelaziz et al., 2011). More studies in human cells,
ideally in primary macrophages,will provide a useful comparison
to the results derived from using mouse infection models.
Immuneeffectormoleculesproducedbyinfectedmacrophages
are likely to play an important role in generating a protective
immune response and warrant further analysis. In mouse and
human macrophages, infection with live L. pneumophila induces
theproductionofinﬂammatorycytokinesandchemokinessuchas
tumornecrosisfactorα(TNF),interleukin(IL)-10,IL-6,IL-1β,IL-
18,CXCL1andMCP-1aswellasIFN-I(Shinetal.,2008;Caseetal.,
2009; Monroe et al., 2009; Plumlee et al., 2009; McCoy-Simandle
et al., 2011), whereas other cytokines such as IL-12 and IFN-γ
appear to be produced at only very low levels,if at all (Matsunaga
et al., 2001, 2003). In whole animals, increased susceptibility to
pulmonary L. pneumophila results from cytokine and/or cytokine
receptor deﬁciencies in IL-12, IFN-γ, and TNF (Brieland et al.,
1998; Shinozawa et al., 2002; Fujita et al., 2008). This suggests
that cytokine production by cell types other than macrophages
is important for controlling infection. At this stage a thorough
understanding of the role of distinct cytokines and immune cells
in combating L. pneumophila lung infection is lacking.
LEGIONELLA PNEUMOPHILA INTERACTIONS WITH DC
Dendritic cells represent a heterogeneous group of cells with spe-
cialized functional properties. DC play a critical role in eliciting
adaptive immune responses through their role as primary anti-
gen presentation cells (Heath and Carbone,2009). Several subsets
of DC are now recognized in the mouse, which began with the
identiﬁcation of CD8− and CD8+ DC in the spleen (Heath and
Carbone, 2009). Further examination of precursor-product rela-
tionships led to the identiﬁcation of distinct end stage subsets of
DC, including CD4−CD8− (double-negative) DC, CD103+, and
CD11b + migratory DC and Langerhans cells, as well as plasma-
cytoid DC (pDC) which are set apart from the other conventional
DC by their gene expression proﬁle. The role of pDC in generat-
ing adaptive immunity is unclear although evidence for a role in
antigen presentation is emerging (Heath and Carbone, 2009).
WerecentlyshowedthatpDCmakeanimportantcontribution
to the restriction of L. pneumophila infection in vivo (Ang et al.,
2010). pDC are known for their ability to combat viral infection
throughtheproductionof IFN-I(Colonnaetal.,2004;Fitzgerald-
Bocarsly et al., 2008). However, a role for pDC in resistance to
bacterialinfectionhadnotbeendescribedbefore.DuringL.pneu-
mophila infection, pDC are rapidly recruited to the lungs of mice
and depletion of pDC signiﬁcantly increases bacterial burden in
the lung (Ang et al., 2010). Currently, the mechanism by which
pDC restrict L. pneumophila infection is not known. However,
it is clear that IFN-I is not necessary as IFN-I-receptor-deﬁcient
(IFNAR−/−) mice are not more severely infected by L. pneu-
mophila compared to wild type mice (Monroe et al., 2009; Ang
et al., 2010). Moreover, depletion of pDC in IFNAR−/− mice
resultsinincreasedbacterialloadinthelung,suggestingthatIFN-
I signaling is dispensable for the anti-bacterial activity of pDC
(Ang et al., 2010). Although L. pneumophila can infect pDC (Ang
et al., 2010), the number of bacteria per host cell is signiﬁcantly
lower compared to macrophages, suggesting that, similar to con-
ventional DC,bacteria do not replicate intracellularly within pDC
(Neild and Roy, 2003). The mechanisms that recruit pDC to the
lung are not yet known but as the primary site of L. pneumophila
replication, macrophages are a likely source of chemoattractant
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cytokines.pDCpresumablythenrespondtoL.pneumophila infec-
tion by producing cytokines that activate neutrophils, NK cells,
and/or macrophages to kill intracellular bacteria (Figure 1). Fur-
ther investigation is needed to determine the mechanisms by
which pDC restrict L. pneumophila infection and importantly
whether these mechanisms are utilized to combat other bacterial
pathogens.
In contrast to macrophages, conventional DC do not allow
replication of L. pneumophila (Neild and Roy, 2003), even if
derivedfromAstrainmice.ThisisdespitethefactthatLCVforma-
tioninDCappearstobesimilartothatinmacrophages(Neildand
Roy, 2003). Restriction of replication by mouse DC is the result
of activation of both caspase-1-dependent pyroptosis and classi-
cal cell death pathways through Bcl-2-associated X (Bax) and Bcl2
antagonist/killer(Bak)mediatedapoptosis(Nogueiraetal.,2009).
The initiation of the intrinsic (mitochondrial) apoptotic pathway
by Bax/Bak leads to early activation of caspase-3 in DC that is
delayed in macrophages (Nogueira et al., 2009). L. pneumophila
is known to induce the intrinsic pathway in macrophages (Hagele
et al., 1998; Gao and Abu Kwaik, 1999; Molmeret et al., 2004;
Abu-Zant et al., 2005; Furugen et al., 2008; Nogueira et al., 2009)
but counteracts the pro-apoptotic stimuli, in part by triggering
NF-κB dependent up-regulation of anti-apoptotic genes (Losick
and Isberg, 2006; Abu-Zant et al., 2007; Bartfeld et al., 2009)a s
well as delivering anti-apoptotic Dot/Icm effectors such as SdhA
and SidF (Laguna et al.,2006;Banga et al.,2007). In fact,SidF acts
directly on pro-apoptotic Bcl2 family members Bcl-rambo and
BNIP3 while the anti-apoptotic mechanism of SdhA seems inde-
pendent of central components of the apoptosis pathway (Laguna
et al., 2006; Banga et al., 2007; Nogueira et al., 2009). It is unclear
whytheseeffectorsarefunctionalinmacrophagesbutdonothave
the same impact in conventional DC, despite the fact that SdhA
appears to be at least partially functional (Nogueira et al., 2009).
Nevertheless, rapid apoptosis is key to the difference between L.
pneumophila replication in macrophages and conventional DC
because adding the anti-apoptotic Dot/Icm effector, AnkG, from
the evolutionarily related pathogen, Coxiella burnetii, inhibits L.
pneumophila inducedapoptosisof DCandreversestherestriction
on bacterial replication (Luhrmann et al., 2010). The importance
ofconventionalDCincontrollingL.pneumophila infectioninvivo
is not known.While DC presumably play a role in antigen presen-
tationandthedevelopmentof anadaptiveresponse,nodirectrole
for conventional DC in controlling L. pneumophila lung infection
has been proven. It has been proposed that DC may act as a dead
FIGURE 1 | Model for the role of pDC in combating L. pneumophila lung
infection. Infected macrophages produce cytokines and chemokines that
recruit pDC to the lung. Bacteria activate pDC viaTLR/NLR interactions or
cytokines from infected macrophages stimulate pDC cytokine production that
then activates neutrophils, NK cells and macrophages to kill bacteria directly
or indirectly.
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end for L. pneumophila replication thereby restricting bacterial
infection but this hypothesis has not been tested directly in vivo,
for example by depletion of conventional DC (Nogueira et al.,
2009).
CONCLUDING REMARKS
Biopsies from patients with Legionnaire’s disease show bac-
teria contained within multi-organism vacuoles in alveolar
macrophages (Chandler et al., 1977; Glavin et al., 1979; Hernan-
dez et al., 1980). In guinea pig and mouse lung infection models,
alveolar macrophages are the ﬁrst cells infected by L. pneumophila
(Winn Jr., 1988; LeibundGut-Landmann et al., 2011). As the ini-
tial niche for bacterial replication, macrophages play a pivotal
role in initiating the host response to L. pneumophila. Indeed
recently, IL-1β production by mouse alveolar macrophages was
shown to activate cytokine responses in airway epithelial cells
(LeibundGut-Landmann et al., 2011). As such, this initial inter-
action with macrophages is likely to be crucial for the recruit-
ment of immune effector cells including neutrophils and NK
cells. In both intravenous and respiratory infection models, IL-
18 is required for IFN-γ production by NK cells (Sporri et al.,
2008;Archeretal.,2009),howeverwhereastheintravenousmodel
of L. pneumophila infection suggested increased susceptibility of
IL-18receptorknockoutmice(measuredbyincreasedsplenicbac-
terial load; Sporri et al., 2008), this result was not validated in
the respiratory infection model (Archer et al., 2009). Therefore it
appears that the role of cytokines and immune cells during lung
infection differs from interactions during systemic responses. T-
and B-cells also ultimately contribute to clear the organism (Susa
etal.,1998;Kikuchietal.,2005;Jolleretal.,2007)buttheirrecruit-
ment and mechanism of activation has not been closely examined
in the context of L. pneumophila infection in vivo. Given that the
resolutionof L.pneumophila infectionrequiresmultiplecelltypes
and abundant cross talk between immune cells, the role of other
cell types such as DC as well as the mechanism of action of pro-
tective cytokines should be examined. The coordinated functions
of these immune components during L. pneumophila infection
invivo islikelytoyieldimportantnewinformationaboutimmune
defense mechanisms in the lung.
ACKNOWLEDGMENTS
This work was supported by grants to Elizabeth L. Hartland and
Ian R. van Driel from theAustralian National Health and Medical
Research Council (NHMRC). Elizabeth L. Hartland is supported
by an Australian Research Council Future Fellowship.
REFERENCES
Abdelaziz, D. H., Gavrilin, M. A.,
Akhter, A., Caution, K., Kotrange,
S., Khweek, A. A., Abdulrahman,
B. A., Grandhi, J., Hassan, Z. A.,
Marsh,C.,Wewers,M.D.,andAmer,
A. O. (2011). Apoptosis-associated
speck-like protein (ASC) controls
Legionella pneumophila infection in
human monocytes. J. Biol. Chem.
286, 3203–3208.
Abu-Zant,A.,Jones,S.,Asare,R.,Suttles,
J.,Price,C.,Graham,J.,andKwaik,Y.
A. (2007). Anti-apoptotic signalling
by the Dot/Icm secretion system of
L. pneumophila. Cell. Microbiol. 9,
246–264.
Abu-Zant,A.,Santic,M.,Molmeret,M.,
Jones, S., Helbig, J., and Abu Kwaik,
Y. (2005). Incomplete activation of
macrophage apoptosis during intra-
cellular replication of Legionella
pneumophila. Infect. Immun. 73,
5339–5349.
Akhter, A., Gavrilin, M. A., Frantz, L.,
Washington, S., Ditty, C., Limoli,
D., Day, C., Sarkar, A., Newland,
C., Butchar, J., Marsh, C. B., Wew-
ers, M. D., Tridandapani, S., Kan-
neganti, T. D., and Amer, A. O.
(2009). Caspase-7 activation by the
Nlrc4/Ipaf inﬂammasome restricts
Legionella pneumophila infection.
PLoS Pathog. 5, e1000361. doi:
10.1371/journal.ppat.1000361
Amer, A., Franchi, L., Kanneganti,
T. D., Body-Malapel, M., Ozoren,
N., Brady, G., Meshinchi, S., Jagir-
dar, R., Gewirtz, A., Akira, S.,
and Nunez, G. (2006). Regulation
of Legionella phagosome matura-
tion and infection through ﬂagellin
and host Ipaf. J. Biol. Chem. 281,
35217–35223.
Ang, D. K., Oates, C. V., Schuelein, R.,
Kelly, M., Sansom, F. M., Bourges,
D., Boon, L., Hertzog, P. J., Hart-
land, E. L., and Van Driel, I. R.
(2010). Cutting edge: pulmonary
Legionellapneumophila iscontrolled
by plasmacytoid dendritic cells but
not type I IFN. J. Immunol. 184,
5429–5433.
Archer,K.A.,Alexopoulou,L.,Flavell,R.
A., and Roy, C. R. (2009). Multiple
MyD88-dependent responses con-
tribute to pulmonary clearance of
Legionella pneumophila. Cell. Micro-
biol. 11, 21–36.
Banga, S., Gao, P., Shen, X., Fiscus, V.,
Zong, W. X., Chen, L., and Luo, Z.
Q. (2007). Legionella pneumophila
inhibits macrophage apoptosis by
targeting pro-death members of the
Bcl2proteinfamily.Proc.Natl.Acad.
Sci. U.S.A. 104, 5121–5126.
Bartfeld,S.,Engels,C.,Bauer,B.,Aurass,
P., Flieger, A., Bruggemann, H.,
and Meyer, T. F. (2009). Tempo-
ral resolution of two-tracked NF-
kappaB activation by Legionella
pneumophila. Cell. Microbiol. 11,
1638–1651.
Beckers, M. C.,Yoshida, S., Morgan, K.,
Skamene, E., and Gros, P. (1995).
Natural resistance to infection with
Legionella pneumophila: chromoso-
mal localization of the Lgn1 sus-
ceptibility gene. Mamm. Genome 6,
540–545.
Brieland,J. K.,Remick,D. G.,Legendre,
M. L., Engleberg, N. C., and Fan-
tone, J. C. (1998). In vivo regula-
tion of replicative Legionella pneu-
mophila lung infection by endoge-
nous interleukin-12. Infect. Immun.
66, 65–69.
Case, C. L., Shin, S., and Roy, C.
R. (2009). Asc and Ipaf Inﬂam-
masomes direct distinct pathways
for caspase-1 activation in response
to Legionella pneumophila. Infect.
Immun. 77, 1981–1991.
Chandler, F. W., Hicklin, M. D., and
Blackmon, J. A. (1977). Demonstra-
tion of the agent of Legionnaires’
diseaseintissue.N.Engl.J.Med.297,
1218–1220.
Coers, J., Vance, R. E., Fontana, M. F.,
and Dietrich, W. F. (2007). Restric-
tion of Legionella pneumophila
growth in macrophages requires the
concerted action of cytokine and
Naip5/Ipaf signallingpathways.Cell.
Microbiol. 9, 2344–2357.
Colonna, M., Trinchieri, G., and Liu,
Y. J. (2004). Plasmacytoid dendritic
cells in immunity. Nat. Immunol. 5,
1219–1226.
Davis, B. K., Wen, H., and Ting, J. P.
(2011). The inﬂammasome NLRs in
immunity, inﬂammation, and asso-
ciateddiseases.Annu. Rev. Immunol.
29, 707–735.
Dietrich, W. F., Damron, D. M., Isberg,
R.R.,Lander,E.S.,andSwanson,M.
S. (1995). Lgn1, a gene that deter-
mines susceptibility to Legionella
pneumophila, maps to mouse chro-
mosome 13. Genomics 26, 443–450.
Diez,E.,Lee,S.H.,Gauthier,S.,Yaraghi,
Z., Tremblay, M., Vidal, S., and
Gros, P. (2003). Birc1e is the gene
within the Lgn1 locus associated
with resistance to Legionella pneu-
mophila. Nat. Genet. 33, 55–60.
Fields,B. S. (1996). The molecular ecol-
ogy of legionellae. Trends Microbiol.
4, 286–290.
Fitzgerald-Bocarsly, P., Dai, J., and
Singh, S. (2008). Plasmacytoid den-
driticcellsandtypeIIFN:50yearsof
convergent history. Cytokine Growth
Factor Rev. 19, 3–19.
Fortier, A., Doiron, K., Saleh, M., Grin-
stein,S.,andGros,P.(2009).Restric-
tionofLegionellapneumophila repli-
cationinmacrophagesrequirescon-
certed action of the transcriptional
regulators Irf1 and Irf8 and NOD-
like receptors Naip5 and Nlrc4.
Infect. Immun. 77, 4794–4805.
Franco, I. S., Shuman, H. A., and Char-
pentier, X. (2009). The perplex-
ing functions and surprising origins
of Legionella pneumophila type IV
secretion effectors. Cell. Microbiol.
11, 1435–1443.
Fraser, D. W., Tsai, T. R., Orenstein, W.,
Parkin, W. E., Beecham, H. J., Shar-
rar, R. G., Harris, J., Mallison, G. F.,
Martin,S.M.,Mcdade,J.E.,Shepard,
C. C., and Brachman, P. S. (1977).
Legionnaires’disease: description of
an epidemic of pneumonia. N. Engl.
J. Med. 297, 1189–1197.
Fujita, M., Ikegame, S., Harada, E.,
Ouchi, H., Inoshima, I., Watanabe,
K., Yoshida, S., and Nakanishi,
Y. (2008). TNF receptor 1 and 2
Frontiers in Microbiology | Cellular and Infection Microbiology June 2011 | Volume 2 | Article 126 | 4Schuelein et al. Immunity to Legionella
contribute in different ways to resis-
tance to Legionella pneumophila-
induced mortality in mice. Cytokine
44, 298–303.
Furugen,M.,Higa,F.,Hibiya,K.,Teruya,
H.,Akamine,M.,Haranaga,S.,Yara,
S., Koide, M., Tateyama, M., Mori,
N., and Fujita, J. (2008). Legionella
pneumophila infection induces pro-
grammed cell death, caspase activa-
tion, and release of high-mobility
groupbox1proteininA549alveolar
epithelial cells: inhibition by methyl
prednisolone. Respir. Res. 9, 39.
Gao, L. Y., and Abu Kwaik, Y. (1999).
Activation of caspase 3 during
Legionella pneumophila-induced
apoptosis. Infect. Immun. 67,
4886–4894.
Glavin,F.L.,Winn,W.C.,Jr.,andCraig-
head, J. E. (1979). Ultrastructure of
lunginLegionnaires’disease.Obser-
vationsofthreebiopsiesdoneduring
the Vermont epidemic. Ann. Intern.
Med. 90, 555–559.
Hagele, S., Hacker, J., and Brand, B. C.
(1998). Legionella pneumophila kills
human phagocytes but not proto-
zoanhostcellsbyinducingapoptotic
celldeath.FEMSMicrobiol.Lett.169,
51–58.
Heath,W.R.,andCarbone,F.R.(2009).
Dendritic cell subsets in primary
and secondary T cell responses at
body surfaces. Nat. Immunol. 10,
1237–1244.
Hernandez, F. J., Kirby, B. D., Stanley,
T. M., and Edelstein, P. H. (1980).
Legionnaires’ disease. Postmortem
pathologic ﬁndings of 20 cases. Am.
J. Clin. Pathol. 73, 488–495.
Horwitz, M. A. (1983a). Formation of
a novel phagosome by the Legion-
naires’disease bacterium (Legionella
pneumophila)inhumanmonocytes.
J. Exp. Med. 158, 1319–1331.
Horwitz, M. A. (1983b). The Legion-
naires’disease bacterium (Legionella
pneumophila) inhibits phagosome-
lysosome fusion in human mono-
cytes. J. Exp. Med. 158, 2108–2126.
Horwitz, M. A., and Silverstein, S.
C. (1980). Legionnaires’ disease
bacterium (Legionella pneumophila)
multiples intracellularly in human
monocytes. J. Clin. Invest. 66,
441–450.
Hubber, A., and Roy, C. R. (2010).
Modulation of host cell function
by Legionella pneumophila type IV
effectors. A n n u .R e v .C e l lD e v .B i o l .
26, 261–283.
Isberg, R. R., O’Connor, T. J., and Hei-
dtman, M. (2009). The Legionella
pneumophila replication vacuole:
makingacosynicheinsidehostcells.
Nat. Rev. Microbiol. 7, 13–24.
Janeway, C. A., Jr. (1992). The immune
system evolved to discriminate
infectious nonself from noninfec-
tiousself.Immunol.Today 13,11–16.
Joller, N., Sporri, R., Hilbi, H., and
Oxenius, A. (2007). Induction and
protective role of antibodies in
Legionella pneumophila infection.
Eur. J. Immunol. 37, 3414–3423.
Kagan, J. C., and Roy, C. R. (2002).
Legionella phagosomes intercept
vesicular trafﬁc from endoplasmic
reticulum exit sites. Nat. Cell Biol. 4,
945–954.
Kikuchi, T., Andarini, S., Xin, H.,
Gomi, K., Tokue, Y., Saijo, Y.,
Honjo, T., Watanabe, A., and
Nukiwa, T. (2005). Involvement of
fractalkine/CX3CL1 expression by
dendritic cells in the enhancement
of host immunity against Legionella
pneumophila. Infect. Immun. 73,
5350–5357.
Laguna, R. K., Creasey, E. A., Li,
Z., Valtz, N., and Isberg, R.
R. (2006). A Legionella pneu-
mophila-translocated substrate that
is required for growth within
macrophages and protection from
host cell death. Proc. Natl. Acad. Sci.
U.S.A. 103, 18745–18750.
Lamkanﬁ, M., Amer, A., Kanneganti,
T. D., Munoz-Planillo, R., Chen,
G., Vandenabeele, P., Fortier, A.,
Gros, P., and Nunez, G. (2007).
TheNOD-likereceptorfamilymem-
ber Naip5/Birc1e restricts Legionella
pneumophila growth independently
of caspase-1 activation. J. Immunol.
178, 8022–8027.
LeibundGut-Landmann, S., Weidner,
K.,Hilbi,H.,andOxenius,A.(2011).
Nonhematopoieticcellsarekeyplay-
ers in innate control of bacterial
airway infection. J. Immunol. 186,
3130–3137.
Lightﬁeld, K. L., Persson, J., Brubaker,
S. W., Witte, C. E., Von Moltke,
J., Dunipace, E. A., Henry, T., Sun,
Y. H., Cado, D., Dietrich, W. F.,
Monack, D. M., Tsolis, R. M., and
Vance, R. E. (2008). Critical func-
tion for Naip5 in inﬂammasome
activation by a conserved carboxy-
terminal domain of ﬂagellin. Nat.
Immunol. 9, 1171–1178.
Losick, V. P., and Isberg, R. R. (2006).
NF-kappaB translocation prevents
host cell death after low-dose chal-
lenge by Legionella pneumophila. J.
Exp. Med. 203, 2177–2189.
Luhrmann,A.,Nogueira,C.V.,Carey,K.
L., and Roy, C. R. (2010). Inhibition
of pathogen-induced apoptosis by
a Coxiella burnetii type IV effector
protein. Proc. Natl. Acad. Sci. U.S.A.
107, 18997–19001.
Matsunaga, K., Klein, T. W., Newton,
C., Friedman, H., and Yamamoto,Y.
(2001). Legionella pneumophila sup-
presses interleukin-12 production
by macrophages. Infect. Immun. 69,
1929–1933.
Matsunaga,K.,Yamaguchi,H.,Klein,T.
W., Friedman, H., and Yamamoto,
Y. (2003). Legionella pneumophila
suppresses macrophage interleukin-
12 production by activating the
p42/44 mitogen-activated protein
kinase cascade. Infect. Immun. 71,
6672–6675.
McCoy-Simandle, K., Stewart, C. R.,
Dao, J., Debroy, S., Rossier, O.,
Bryce, P. J., and Cianciotto, N. P.
(2011). Legionella pneumophila type
II secretion dampens the cytokine
response of infected macrophages
and epithelia. Infect. Immun. 79,
1984–1997.
McDade, J. E., Shepard, C. C., Fraser,
D. W., Tsai, T. R., Redus, M. A., and
Dowdle,W. R. (1977). Legionnaires’
disease:isolation of a bacterium and
demonstration of its role in other
respiratory disease. N .E n g l .J .M e d .
297, 1197–1203.
Miao, E. A., Leaf, I. A., Treuting, P.
M., Mao, D. P., Dors, M., Sarkar,
A., Warren, S. E., Wewers, M. D.,
and Aderem, A. (2010). Caspase-
1-induced pyroptosis is an innate
immuneeffectormechanismagainst
intracellularbacteria.Nat.Immunol.
11, 1136–1142.
Molmeret, M., Zink, S. D., Han, L.,
Abu-Zant, A., Asari, R., Bitar, D.
M., and Abu Kwaik, Y. (2004).
Activation of caspase-3 by the
Dot/Icm virulence system is essen-
tial for arrested biogenesis of the
Legionella-containing phagosome.
Cell. Microbiol. 6, 33–48.
Molofsky, A. B., Byrne, B. G., Whit-
ﬁeld, N. N., Madigan, C. A., Fuse,
E. T., Tateda, K., and Swanson,
M. S. (2006). Cytosolic recog-
nition of ﬂagellin by mouse
macrophages restricts Legionella
pneumophila infection. J. Exp. Med.
203, 1093–1104.
Monroe, K. M., Mcwhirter, S. M., and
Vance,R. E. (2009). Identiﬁcation of
host cytosolic sensors and bacterial
factors regulating the type I inter-
feron response to Legionella pneu-
mophila. PLoS Pathog. 5, e1000665.
doi: 10.1371/journal.ppat.1000665
Neild, A. L., and Roy, C. R. (2003).
Legionella reveal dendritic cell func-
tions that facilitate selection of anti-
gens for MHC class II presentation.
Immunity 18, 813–823.
Newton, H. J., Ang, D. K., Van Driel,
I. R., and Hartland, E. L. (2010).
Molecular pathogenesis of infec-
tions caused by Legionella pneu-
mophila. Clin. Microbiol. Rev. 23,
274–298.
Nogueira, C. V., Lindsten, T., Jamieson,
A. M., Case, C. L., Shin, S.,
Thompson, C. B., and Roy, C.
R. (2009). Rapid pathogen-induced
apoptosis: a mechanism used by
dendritic cells to limit intracellu-
lar replication of Legionella pneu-
mophila. PLoS Pathog. 5, e1000478.
doi: 10.1371/journal.ppat.1000478
Plumlee, C. R., Lee, C., Beg, A. A.,
Decker, T., Shuman, H. A., and
Schindler, C. (2009). Interferons
direct an effective innate response to
Legionella pneumophila infection. J.
Biol. Chem. 284, 30058–30066.
Ren, T., Zamboni, D. S., Roy, C.
R., Dietrich, W. F., and Vance,
R. E. (2006). Flagellin-deﬁcient
Legionella mutants evade caspase-
1- and Naip5-mediated macrophage
immunity. PLoS Pathog. 2, e18. doi:
10.1371/journal.ppat.0020018
Rowbotham, T. J. (1980). Prelimi-
nary report on the pathogenicity of
Legionella pneumophila for freshwa-
ter and soil amoebae. J. Clin. Pathol.
33, 1179–1183.
Roy, C. R., and Tilney, L. G. (2002).
The road less traveled: transport
of Legionella to the endoplas-
mic reticulum. J. Cell Biol. 158,
415–419.
Schroder, K., and Tschopp, J. (2010).
The inﬂammasomes. Cell 140,
821–832.
Segal, G., Purcell, M., and Shuman, H.
A. (1998). Host cell killing and bac-
terial conjugation require overlap-
ping sets of genes within a 22-kb
regionoftheLegionellapneumophila
genome. Proc. Natl.Acad. Sci. U.S.A.
95, 1669–1674.
Segal, G., and Shuman, H. A. (1997).
Characterization of a new region
required for macrophage killing
by Legionella pneumophila. Infect.
Immun. 65, 5057–5066.
Shin, S., Case, C. L., Archer, K.
A., Nogueira, C. V., Kobayashi,
K. S., Flavell, R. A., Roy, C. R.,
and Zamboni, D. S. (2008). Type
IV secretion-dependent activation
of host MAP kinases induces an
increasedproinﬂammatorycytokine
response to Legionella pneumophila.
PLoS Pathog. 4, e1000220. doi:
10.1371/journal.ppat.1000220
Shinozawa, Y., Matsumoto, T., Uchida,
K., Tsujimoto, S., Iwakura, Y.,
and Yamaguchi, K. (2002). Role
of interferon-gamma in inﬂam-
matory responses in murine res-
piratory infection with Legionella
pneumophila. J. Med. Microbiol. 51,
225–230.
Silveira, T. N., and Zamboni, D. S.
(2010). Pore formation triggered
by Legionella spp. is an Nlrc4
inﬂammasome-dependent host cell
response that precedes pyroptosis.
Infect. Immun. 78, 1403–1413.
www.frontiersin.org June 2011 | Volume 2 | Article 126 | 5Schuelein et al. Immunity to Legionella
Sporri, R., Joller, N., Hilbi, H., and
Oxenius, A. (2008). A novel role
for neutrophils as critical activa-
tors of NK cells. J. Immunol. 181,
7121–7130.
Susa, M., Ticac, B., Rukavina, T., Doric,
M., and Marre, R. (1998). Legionella
pneumophila infection in intratra-
cheally inoculated T cell-depleted or
-nondepleted A/J mice. J. Immunol.
160, 316–321.
Takeuchi, O., and Akira, S. (2010).
Pattern recognition receptors and
inﬂammation. Cell 140, 805–820.
Tyndall, R. L., and Domingue, E. L.
(1982). Cocultivation of Legionella
pneumophila and free-living amoe-
bae. Appl. Environ. Microbiol. 44,
954–959.
Vinzing, M., Eitel, J., Lippmann, J.,
Hocke, A. C., Zahlten, J., Slevogt,
H., N’Guessan P, D., Gunther, S.,
Schmeck, B., Hippenstiel, S., Flieger,
A., Suttorp, N., and Opitz, B.
(2008). NAIP and Ipaf control
Legionella pneumophila replication
in human cells. J. Immunol. 180,
6808–6815.
Vogel, J. P.,Andrews, H. L.,Wong, S. K.,
andIsberg,R.R.(1998).Conjugative
transfer by the virulence system of
Legionellapneumophila.Science 279,
873–876.
Weber, S. S., Ragaz, C., and Hilbi, H.
(2009). Pathogen trafﬁcking path-
ways and host phosphoinositide
metabolism. Mol. Microbiol. 71,
1341–1352.
Winn, W. C., Jr. (1988). Legionnaires
disease: historical perspective. Clin.
Microbiol. Rev. 1, 60–81.
Wright, E. K., Goodart, S. A., Growney,
J. D., Hadinoto, V., Endrizzi, M. G.,
Long, E. M., Sadigh, K., Abney, A.
L., Bernstein-Hanley, I., and Diet-
rich,W. F. (2003). Naip5 affects host
susceptibility to the intracellular
pathogen Legionella pneumophila.
Curr. Biol. 13, 27–36.
Yamamoto, Y., Klein, T. W., Newton,
C. A., Widen, R., and Friedman,
H. (1988). Growth of Legionella
pneumophila in thioglycolate-
elicited peritoneal macrophages
from A/J mice. Infect. Immun. 56,
370–375.
Zamboni,D. S.,Kobayashi,K. S.,Kohls-
dorf, T., Ogura, Y., Long, E. M.,
Vance,R. E.,Kuida,K.,Mariathasan,
S., Dixit, V. M., Flavell, R. A., Diet-
rich,W.F.,andRoy,C.R.(2006).The
Birc1e cytosolic pattern-recognition
receptor contributes to the detec-
tion and control of Legionella pneu-
mophila infection. Nat. Immunol. 7,
318–325.
Zhu, W., Banga, S., Tan, Y., Zheng,
C., Stephenson, R., Gately, J., and
Luo, Z. Q. (2011). Comprehensive
identiﬁcation of protein substrates
of the Dot/Icm type IV transporter
of Legionella pneumophila. PLoS
ONE, 6, e17638. doi: 10.1371/jour-
nal.pone.0017638
Conﬂict of Interest Statement: The
authors declare that the research was
conducted in the absence of any
commercial or ﬁnancial relationships
that could be construed as a potential
conﬂict of interest.
Received: 29 April 2011; paper pend-
ing published: 15 May 2011; accepted:
23 May 2011; published online: 03 June
2011.
Citation: Schuelein R, Ang DKY, van
Driel IR and Hartland EL (2011)
Immune control of Legionella infection:
an in vivo perspective. Front. Microbio.
2:126. doi: 10.3389/fmicb.2011.00126
This article was submitted to Frontiers
in Cellular and Infection Microbiology, a
specialty of Frontiers in Microbiology.
Copyright © 2011 Schuelein, Ang, van
Driel and Hartland. This is an open-
access article subject to a non-exclusive
license between the authors and Frontiers
Media SA, which permits use, distribu-
tion and reproduction in other forums,
provided the original authors and source
are credited and other Frontiers condi-
tions are complied with.
Frontiers in Microbiology | Cellular and Infection Microbiology June 2011 | Volume 2 | Article 126 | 6